Dr Tzvi Gerstl, CEO of Synamedia (Image Credit: PRNewswire)

M42’s Healthpoint Elevates Patient Mobility Through Integrated Care

Dr. Nahla Al Mansoori, Head of Plastic & Reconstructive Surgery at Healthpoint (Image Credit: Zawya)
Dr. Nahla Al Mansoori, Head of Plastic & Reconstructive Surgery at Healthpoint (Image Credit: Zawya)

Healthpoint, part of the M42 group, has supported a patient in reclaiming her daily life after years of living with lymphedema, through a specialised, multidisciplinary approach to care.

For a long time, 37-year-old Maryam Al Rais adjusted her life around a condition she couldn’t fully control. The swelling in her leg was persistent, often painful, and increasingly difficult to ignore. Over time, it began to dictate small but significant choices, from how long she could stay on her feet to whether she felt comfortable leaving the house at all.

“It slowly took over my routine. Everything revolved around how I was feeling physically; some days I could cope, and others I simply couldn’t,” she said.

Eventually diagnosed with lymphedema, a chronic condition affecting the lymphatic system that causes persistent swelling, most commonly in the arms or legs, Maryam faced ongoing challenges with mobility, comfort, and overall wellbeing. After experiencing a recurrence following a previous unsuccessful procedure, she turned to Healthpoint for a more comprehensive treatment pathway, enrolling in a personalised programme tailored to support her long-term recovery and management.

“What stood out for me was that it wasn’t just about one solution,” she added. “It was the first time someone explained how everything connects, and what I could do long-term. Since the procedure I have reduced swelling and improved mobility, this has allowed me to return more comfortably to everyday activities that were previously difficult”

As part of this programme, and under the care of Dr. Nahla Al Mansoori, Head of Plastic & Reconstructive Surgery at Healthpoint, Maryam’s treatment plan was designed to support both immediate recovery and long-term management of lymphedema.

While advances in super microsurgical interventions such as lymphatic venous anastomosis (LVA) and vascularized lymph node transfer (VLNT) offer a physiological approach to restoring lymphatic drainage, they are most effective when delivered as part of a broader, multidisciplinary strategy rather than as standalone solutions. Maryam underwent LVA and VLNT in a procedure lasting approximately six hours, as part of a holistic treatment plan supported by rehabilitation, ongoing monitoring, and lifestyle guidance. Achieving optimal outcomes requires integration with comprehensive conservative care, including physiotherapy, compression therapy, psychological support and weight management.

(Image Credit: Healthpoint and M42 official websites)
(Image Credit: Healthpoint and M42 official websites)

“There is no single solution for lymphedema, which makes setting the right expectations an important part of care,” Dr. Nahla said. “At Healthpoint, our focus is on supporting patients beyond surgery, through a multidisciplinary approach that combines advanced microsurgical interventions with rehabilitation and long-term support to help improve mobility, ease the impact of the condition, and restore quality of life.”

Through its expanded plastic and reconstructive surgery programme, Healthpoint continues to strengthen its role as a leading centre in the UAE for lower extremity lymphedema, offering advanced super microsurgical interventions within a structured, multidisciplinary care model focused on long-term, sustainable outcomes.

Maryam continues to follow her personalized care plan, with regular monitoring and support. She is now able to move more freely and return to daily routines with greater comfort and confidence.

Source

For more similar news on healthcare, check links below:

Avio Health Launches World’s First Functional Medicine LLM for Emagene Life, Transforming Personalized Healthcare

NHS England accelerates AI adoption with Microsoft 365 Copilot for Healthcare Operations

Egret Therapeutics Signs MoU with Genexine to acquire GX-P1

(Visited 3 times, 3 visits today)

Share:

Facebook
Twitter
WhatsApp
LinkedIn

 

Comments are closed.

  • 4 Fintech Week Awards & Expo - 16 to 17 Sep 2026

Social Media

Most Popular

Atomic Mobile Supports Connectivity for International Media Covering the FIFA World Cup (Image Credit: Atomic Mobile LinkedIn page)
Atomic Mobile Strengthens Connectivity for FIFA World Cup Media Coverage
Changan Automobile announces partnership with the Portugal National Football Team (Image Credit: PRNewswire)
Changan Automobile Announces Partnership with the Portugal National Football Team
Death Wish Coffee Co.'s Power Surge (Image Credit: PRNewswire)
Death Wish Coffee Co. Introduces Power Surge
Vocelli Pizza Launches a New High Protein Pinsa Crust (Image Credit: PRNewswire)
Vocelli Introduces Protein-Rich Pinsa Pizza Crust

Related Posts